| Name | DLK-IN-1 |
|---|---|
| Synonyms |
2-Pyridinamine, 5-[1-(1-methylethyl)-5-[(1α,5α,6α)-3-(3-oxetanyl)-3-azabicyclo[3.1.0]hex-6-yl]-1H-pyrazol-3-yl]-3-(trifluoromethoxy)
DLK IN 1,DLKIN1 DLK-IN-14 DLK inhibitor 1 |
| Description | DLK-IN-1 is a selective inhibitor of dual leucine zipper kinase (DLK, MAP3K12), with a Ki of 3 nM. DLK-IN-1 retains excellent CNS penetration and is well tolerated following multiple days of dosing at concentrations that exceed those required for DLK inhibition in the brain. DLK-IN-1 has activity in a model of Alzheimer’s Disease. |
|---|---|
| Related Catalog | |
| Target |
Ki: 3 nM (DLK)[1]. |
| References |
| Molecular Formula | C20H24F3N5O2 |
|---|---|
| Molecular Weight | 423.43 |
| Storage condition | 2-8℃ |